Drug Profile
Centanamycin
Alternative Names: AS-1-145; D716970; ML-970; NSC 716970Latest Information Update: 10 Aug 2021
Price :
$50
*
At a glance
- Originator Hope College; Spirogen
- Developer Hope College; National Cancer Institute (USA); Spirogen
- Class Amides; Antimalarials; Cytostatic antibiotics; Indoles; Naphthalenes
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer; Malaria
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in USA
- 04 Nov 2017 No recent reports of development identified for preclinical development in Malaria in USA
- 15 Oct 2013 Spirogen has been acquired by MedImmune